GENinCode

GENinCode Specializes in Cardiovascular Disease Risk. Cardiovascular disease is the leading cause of death and disability worldwide.GENinCode products integrate genetic and clinical data to assess patient risk, providing healthcare practitioners with advanced clinical information to evaluate and predict the onset of cardiovascular disease.Our products help inform patients of their health risks, enabling them to modify behaviors or "lifestyles," while offering doctors better genetic insights and clinical information to determine the most effective treatment pathways (precision medicine).GENinCode predictive technology provides patients and doctors with globally leading preventive care and treatment strategies. Our molecular tests, combined with clinical algorithms and artificial intelligence, deliver advanced patient risk assessments to predict disease onset.GENinCode has over 15 years of research and development experience in the field of cardiovascular health genomics, accumulating deep understanding and insight into the interactions between patients' genetic profiles, lifestyles, and clinical risk factors.